HSC835
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HSC835, covering 2017-05-12 to 2017-08-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant [Phase 2]